| Document |
Document Title |
|
WO/2020/034058A1 |
A process for the reductive amination of an α,β-unsaturated carbonyl compound and a process for the preparation of a tetrathydrofuran-derived amine starting from furfural or a derivative thereof.
|
|
WO/2020/034062A1 |
The invention relates to a process for the reductive amination of a carbonyl compound. The invention furthermore relates to a process for the preparation of a furan-derived amine starting from furfural or a derivative thereof.
|
|
WO/2020/036382A1 |
The present invention relates to a method for producing an intermediate useful for the synthesis of a diphenylmethane derivative that can be used as a SGLT inhibitor. A method for synthesizing a compound of formula 7 according to the pre...
|
|
WO/2020/031107A1 |
The invention is directed to substituted tetrahydrofuran derivatives. Specifically, the invention is directed to compounds according to Formula (I), wherein C, D, L1, L2, R1, R2, R3, R4, R5, R6, Y1, Y2, z1, z2, z3, z4, X1, X2, X3, X4, X5...
|
|
WO/2020/029846A1 |
Disclosed by the present invention is a rapid synthesis method for a biomass-based amine compound, comprising: by using formamide as an amine source, using formic acid as a hydrogen source, and using biomass aldehydes and ketones as raw ...
|
|
WO/2020/027323A1 |
An organic electroluminescent element which comprises a negative electrode, a positive electrode and a light emitting layer that is arranged between the negative electrode and the positive electrode, and which is configured such that the...
|
|
WO/2020/027150A1 |
A compound represented by general formula (I) (wherein each symbol is as defined in the description) or a salt thereof has a potent neural protecting and/or repairing effect and, therefore, is usable as a therapeutic agent for neurologic...
|
|
WO/2020/022779A1 |
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.
|
|
WO/2020/023356A1 |
The present invention provides compounds of formula (I) wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of prolif...
|
|
WO/2020/015675A1 |
The present invention belongs to the technical field of semiconductors. Disclosed are a compound having triarylamine as a core and an application thereof. The structure of the compound provided in the present invention is represented by ...
|
|
WO/2020/014195A1 |
The present application discloses compounds and compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
|
|
WO/2020/012403A1 |
The present invention relates to an improved process for diastereoselective synthesis of vicinal diamines (1). The process involves highly regio- and diastereoselective addition of 2-azaallyl anions (4) to N-tert-butanesulfinylimines (5)...
|
|
WO/2020/012830A1 |
The production method comprises reacting hydrogen, carbon monoxide, and a specific alcohol having an unsaturated bond, in the presence of a base, a tertiary phosphite ligand, and a transition metal compound from Group 8 to Group 10, ther...
|
|
WO/2020/011996A1 |
The present invention relates to a process for the production and separation of 5-hydroxymethylfurfural (HMF) comprising the steps of: (1) dehydrating at least one saccharide selected from the group consisting of monosaccharides having 6...
|
|
WO/2020/014304A1 |
Compositions of furan based surfactants derived from unsaturated carbon-containing molecules, such as fatty acids, as well as methods for forming furan based surfactants from unsaturated carbon-containing molecules, such as fatty acids, ...
|
|
WO/2020/009554A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2020/009518A1 |
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2020/008183A1 |
Disclosed herein are novel and inventive methods for preparing intermediates in the synthesis of C3-substituted cephalosporins. One preferred C3-substituted cephalosporin of clinical interest is Cefovecin. Accordingly, the present invent...
|
|
WO/2020/009433A1 |
The present specification relates to a heterocyclic compound in chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2020/009381A1 |
The present invention relates to a novel organic compound and an organic electroluminescent device using same and, more particularly, to a novel compound having excellent light-emitting ability and an organic electroluminescent device ha...
|
|
WO/2020/009958A1 |
A set of small molecules ERα biomodulators that kill therapy-resistant ERα positive breast, ovarian, and endometrial cancer cells. These small molecules have increased therapeutic potential because of an increased ability to kill thera...
|
|
WO/2020/009442A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/009441A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/010346A1 |
The invention relates to a use of a compound for manufacturing a medicament for treating an allergic disease, wherein the compound is selected from the group consisting of ovatodiolide, 1'-acetoxychavicol acetate, zerumbone and combinati...
|
|
WO/2020/002238A1 |
The present invention provides compounds of formula (I) for use in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).
|
|
WO/2020/006476A1 |
The present invention provides processes for the synthesis of organic azides, intermediates for the production thereof, and compositions related thereto.
|
|
WO/2020/001298A1 |
Provided in the present invention are a 4-(p-trifluoromethylbenzyl)-3-floro-1,2,4 triphenylamine derivative, a pharmaceutical composition of same, and uses thereof. The chemical formula of the derivative is as represented by formula I, w...
|
|
WO/2020/005607A1 |
Disclosed herein is a very efficient method to make 5- (alkoxycarbonyl)furan-2-carboxylic acids (ACFC) from feedstocks comprised of furoates. When a feedstock comprised of methyl 5-methylfuran-2- carboxylate (MMFC) is used a product comp...
|
|
WO/2019/242192A1 |
The present invention relates to a brivaracetam intermediate, a preparation method therefor, and a preparation method for brivaracetam. The steps of the method for preparing brivaracetam described in the present invention are short and t...
|
|
WO/2019/242780A1 |
Intermediates used for preparing brivaracetam, preparation methods for the intermediates, and a use. The present invention comprises an intermediate compound A and an intermediate compound B, preparation methods therefor, and a synthetic...
|
|
WO/2019/244166A1 |
The present invention relates to a new protocol for "Process development for 5-hydroxymethylfurfural (5-HMF) synthesis from carbohydrates". A convenient, atom-economic, highly selective and cost-effective process has been developed for t...
|
|
WO/2019/245898A1 |
A method for producing an aromatic dianhydride includes reacting an aromatic diimide with a substituted or unsubstituted phthalic anhydride in an aqueous medium in the presence of an amine exchange catalyst to provide an aqueous reaction...
|
|
WO/2019/242765A1 |
The present invention provides a compound represented by the formula (I) or an optical isomer thereof, and a tautomer, a pharmaceutically acceptable salt, a prodrug, a hydrate, or a solvate. The various deuterated compounds and salts and...
|
|
WO/2019/242692A1 |
The present application provides a compound in formula III, and further provides a use of the compound in the synthesis of a Brivaracetam intermediate and a crude drug, and a synthesis method. A raw material involved in the method of the...
|
|
WO/2019/246034A1 |
Compositions and methods are disclosed for the production of bio-based polymers (e.g., polymers made from glucose), including polyesters, as well as end products resulting from such production, in which one or more color stabilizing addi...
|
|
WO/2019/237645A1 |
The present invention provides a strigolactone structural analog, a preparation method therefor and use thereof. The structural formula is as represented by formula I:. The strigolactone structural analog provided by the present inventio...
|
|
WO/2019/240532A1 |
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic light-emitting device including same.
|
|
WO/2019/239341A1 |
The invention relates to a process for the asymmetric synthesis of (R)-4-propyldihydrofuran-2(3H)-one starting with trans-2-hexen-l-al and nitromethane, wherein the stereocentre is generated for the first time by an organocatalytic metho...
|
|
WO/2019/232664A1 |
A sulfonyl substituted furan compound having anti-inflammatory immune activity and a derivative thereof, represented by the following formula (I):. The compound and a derivative thereof have anti-inflammatory immune activity.
|
|
WO/2019/235902A1 |
The present specification provides a compound of chemical formula 1 and an organic electronic element comprising same.
|
|
WO/2019/235845A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2019/236988A1 |
Provided herein are methods, reagents, and kits for isolating polypeptides, such as a proteome. Also provided herein is a modified trypsin polypeptide that is resistant to autolysis, and that can be selectively-separated from a biologica...
|
|
WO/2019/235875A1 |
The present specification provides a compound of chemical formula 1 and an organic light-emitting diode comprising same.
|
|
WO/2019/236536A1 |
A method for producing an aromatic dianhydride includes reacting an aromatic diimide with a substituted or unsubstituted phthalic anhydride in an aqueous medium in the presence of an amine exchange catalyst to provide an aqueous reaction...
|
|
WO/2019/228994A1 |
This invention relates to oleic acid derivative comprising a hydrophobic part C17H33 linked to a particular polar head part "A", especially for use as a medicament, for instance, for the treatment of a disorder caused by the GPR120 recep...
|
|
WO/2019/231272A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.
|
|
WO/2019/228874A1 |
The present invention relates stereoselective synthesis of enantiomerically enriched pantolactone.
|
|
WO/2019/231210A1 |
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2019/228873A1 |
The invention relates to an improved synthesis of a racemic mixture of pantolactone (I).
|
|
WO/2019/229080A1 |
The present invention relates to a process for preparing 5-hydroxymethylfurfural (HMF) which converts a fructose-containing component, using a catalyst system that comprises a mixture of salt and acid at a temperature of 90 to 200°C and...
|
